Clinical Trial Update: Early Angiotensin II in the Emergency Department [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating early use of angiotensin II in the emergency department for septic shock. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• Angiotensin II (angiotensin II)

Snippet

Sponsor: Brett A Faine | Conditions: Septic Shock | Phase 4 | Status: RECRUITING